0001567619-21-012046.txt : 20210614 0001567619-21-012046.hdr.sgml : 20210614 20210614144704 ACCESSION NUMBER: 0001567619-21-012046 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20210614 DATE AS OF CHANGE: 20210614 EFFECTIVENESS DATE: 20210614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pacylex Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001866841 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-402780 FILM NUMBER: 211014207 BUSINESS ADDRESS: STREET 1: 10230 JASPER AVENUE, SUITE 4000 CITY: EDMONTON STATE: A0 ZIP: T5J 4P6 BUSINESS PHONE: 780-264-4295 MAIL ADDRESS: STREET 1: 10230 JASPER AVENUE, SUITE 4000 CITY: EDMONTON STATE: A0 ZIP: T5J 4P6 D 1 primary_doc.xml X0708 D LIVE 0001866841 Pacylex Pharmaceuticals Inc. 10230 JASPER AVENUE, SUITE 4000 EDMONTON A0 ALBERTA, CANADA T5J 4P6 780-264-4295 CANADA (FEDERAL LEVEL) None None Corporation true Cindy Jacobs c/o Pacylex Pharmaceuticals Inc. 10230 Jasper Avenue, Suite 4000 Edmonton A0 ALBERTA, CANADA T5J 4P6 Director Mark Huson c/o Pacylex Pharmaceuticals Inc. 10230 Jasper Avenue, Suite 4000 Edmonton A0 ALBERTA, CANADA T5J 4P6 Director Michael Weickert c/o Pacylex Pharmaceuticals Inc. 10230 Jasper Avenue, Suite 4000 Edmonton A0 ALBERTA, CANADA T5J 4P6 Executive Officer Director Luc G. Berthiaume c/o Pacylex Pharmaceuticals Inc. 10230 Jasper Avenue, Suite 4000 Edmonton A1 BRITISH COLUMBIA, CANADA T5J 4P6 Director John Mackey c/o Pacylex Pharmaceuticals Inc. 10230 Jasper Avenue, Suite 4000 Edmonton A0 ALBERTA, CANADA T5J 4P6 Director Ryan Heit c/o Pacylex Pharmaceuticals Inc. 10230 Jasper Avenue, Suite 4000 Edmonton A0 ALBERTA, CANADA T5J 4P6 Executive Officer Ajit Gill c/o Pacylex Pharmaceuticals Inc. 10230 Jasper Avenue, Suite 4000 Edmonton A0 ALBERTA, CANADA T5J 4P6 Director Pharmaceuticals Decline to Disclose 06c false 2021-05-28 false true true false 0 7184198 7184198 0 This filing covers, in part, the sale of common shares issued as a result of the conversion of promissory notes. false 6 0 0 0 false Pacylex Pharmaceuticals Inc. /s/ Ryan Heit Ryan Heit Chief Operating Officer 2021-06-14